SCHEMBL21573785

SCHEMBL21573785

CC(=O)NCC1CC1P

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17249606 0.79 — —
SCHEMBL21573802 0.77 — —
SCHEMBL1901026 0.77 FUCA1 (0.39) —
SCHEMBL17249604 0.77 — —
SCHEMBL1866565 0.74 FUCA1 (0.40) —
SCHEMBL10106984 0.74 CYP2C9 (0.49) —
SCHEMBL22482094 0.73 FUCA1 (0.47) —
SCHEMBL24133924 0.71 FUCA1 (0.38) —
SCHEMBL13809942 0.71 CYP2C9 (0.38) —
SCHEMBL13809941 0.71 CYP2C9 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3247705-B1 QUINAZOLINE AND QUINOLINE COMPOUNDS AND USES THEREOF AS NAMPT INHIBITORS MILLENNIUM PHARM INC (US) 2019-11-20 — — EP disclosed
Send feedback